Related Experiment Video
Updated: Jun 20, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[Hyperglycemia, morbidity and mortality in critically ill children: critical analysis based on a systematic review]
Eduardo Mekitarian Filho1, Werther Brunow de Carvalho, Eduardo Juan Troster
1Instituto da Criança Professor Pedro de Alcântara da Universidade de São Paulo, S. Paulo, Brazil. emf2002@uol.com.br
Insights
Hyperglycemia in critically ill children admitted to the pediatric intensive care unit (PICU) is linked to increased morbidity and mortality. Further prospective studies are needed to confirm these findings and address methodological limitations.
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Clinical Research Methodology
Background:
- Hyperglycemia is a common metabolic derangement in critically ill pediatric patients.
- The impact of hyperglycemia on morbidity and mortality in this population requires thorough investigation.
Purpose of the Study:
- To determine if hyperglycemia is a risk factor for increased morbidity and mortality in critically ill pediatric patients.
- To critically analyze existing pediatric and neonatology literature on this topic.
Main Methods:
- Systematic literature review of Medline, Cochrane, Lilacs, and Embase databases.
- Inclusion of cohort studies (retrospective and prospective) in Portuguese, English, and Spanish.
- Evaluation of outcomes including PICU and hospital mortality, length of stay, infection risk, and mechanical ventilation time.
Main Results:
- 79 articles were initially selected, with 15 cohort studies (2 prospective, 13 retrospective) analyzed.
- Analysis of cohort studies indicated that hyperglycemia increases morbidity, mortality, and length of stay in the PICU for critically ill children.
Conclusions:
- Hyperglycemia, whether isolated or persistent, is associated with worse outcomes in critically ill children.
- Methodological limitations in existing studies, including glucose measurement protocols and study design, necessitate further prospective research.
- Hyperglycemia's role as a singular predictor of morbidity and mortality in pediatrics requires additional investigation.
Objective:
This article focused on verifying if hyperglycemia in critically ill pediatric patients is a risk factor for increased morbidity and mortality and carried out a critical analysis of the articles in pediatrics and neonatology.
Methods:
A systematic review of literature was performed using Medline, Cochrane, Lilacs and Embase databases and references of articles. Articles written in Portuguese, English and Spanish were selected and the terms used in the search were hyperglycemia, intensive care units (pediatrics), hospitals, pediatrics and pediatric intensive care. Cohort studies, retrospective and prospective, were selected for analysis. The outcomes evaluated were mortality during pediatric intensive care unit (PICU) stay, mortality during hospital stay, length-of-stay in the PICU, mortality due to specific diseases, and risk of infection and time of mechanical ventilation.
Results:
During the study period 79 articles related to hyperglycemia in critically ill pediatric patients were selected; 15 (19%) were cohort studies (2 prospective and 13 retrospective) that were analyzed separately.
Conclusion:
Analysis of these cohort studies supported the conclusion that hyperglycemia, isolated or persistent during stay in PICU, increases morbidity, mortality and length-of-stay in PICU of critically ill children. However, these studies disclosed methodological issues such as lack of protocols for glucose measurement, design (most of them retrospective cohorts) and many articles did not confirm hyperglycemia as a single predictor of morbidity and mortality in pediatrics; therefore further prospective studies are necessary.
Related Concept Videos
Hyperglycemia
Hypoglycemia and Glucagon
Hypoglycemia
Diabetes: Symptoms, Diagnosis, and Complications
Complications of Diabetes Mellitus
Diabetes Mellitus: Type 2 and Gestational
